TCT-364 Difference Of Stent Expansion Between Thin Strut Cobalt Chromium Platform And Thick Strut Stainless Platform In Calcified Lesions

TCT-364 Difference Of Stent Expansion Between Thin Strut Cobalt Chromium Platform And Thick Strut Stainless Platform In Calcified Lesions

Background Although it has been recognized that thin strut cobalt chromium everolimus-eluting stent (EES; Xience) is associated with less target lesion failure, it has lower radial force, and it had failed to prove superiority to thick strut paclitaxel-eluting stent in diabetes in some studies.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2014-09, Vol.64 (11), p.B106-B106
Hauptverfasser: Tsubata, Hideo, Yamada, Shinichiro, Yasaka, Yoshinori, Kobayashi, Seiichi, Sawada, Takahiro, Oishi, Shogo, Toba, Takayoshi, Miyata, Taishi, Chimura, Misato, Kawai, Hiroya
Format: Artikel
Sprache:eng
Schlagworte:
Angioplasty
Calcification
Cardiology
Cardiovascular
Chromium
Diabetes
Expansion
Internal Medicine
Stents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Although it has been recognized that thin strut cobalt chromium everolimus-eluting stent (EES; Xience) is associated with less target lesion failure, it has lower radial force, and it had failed to prove superiority to thick strut paclitaxel-eluting stent in diabetes in some studies.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.07.411